Q&A with Christopher Park, investment director, UL Ventures
Month: September 2021
Investors serve Good Meat with $267m
Eat Just’s cultured meat subsidiary secured the funding from new and returning backers four months after a $170m tranche of the round.
Airwallex accesses $200m at $4bn valuation
Payment technology provider Airwallex was valued at $4bn in its series E round, following earlier funding from Salesforce, ANZ Bank, Tencent and Mastercard.
SoftBank sheds $1.69bn of Coupang shares
SoftBank has divested 57 million of its 625 million shares in the NYSE-listed e-commerce marketplace, having invested $3bn between 2015 and 2018.
Blueground accommodates $180m series C round
Jabbar Internet Group-backed flexible rental property provider Blueground has pulled in $140m of equity funding and $40m of debt through its latest funding round.
AvidXchange seeks Nasdaq listing
The Mastercard-backed payment software provider has raised over $1.2bn pre-IPO and has opted to float on the Nasdaq Global Select Market.
Illumina Ventures introduces $325m Fund II
Illumina has anchored the second fund to be closed by the venture firm it sponsors, with Ireland Strategic Investment Fund among the limited partners.
Pyxis Oncology files for IPO
The cancer treatment developer is set to go public in an offering which would represent exits for Pfizer Ventures, Leaps by Bayer and Ipsen.
Lightricks shines with $130m series D
The content creation tool developer was valued at $1.8bn through a series D round featuring Access Industries’ ClalTech unit, Harel Insurance and Finance and Migdal Insurance.
Monese monetises interest to raise $90m
Investec has returned to provide the first tranche of the PayPal and Avios-backed banking platform developer’s series C round, taking its total funding to $162m.
Tradesy traps $67m in series D round
The luxury fashion re-sale platform, which counts Virgin among its earlier investors, has pushed its overall funding past the $140m mark.
Grailed sells Goat on $60m series B
Goat Group led the online streetwear marketplace’s series B round, which lifted its overall funding to $80m.
Arctos accepts Novartis acquisition offer
Arctos Medical, which is developing gene therapies to treat sight loss, had raised $8.1m from investors including Novartis two years ago.
Kotak Mahindra okays $42m KFin investment
The investors-focused digital services provider is set to raise the cash from Kotak Mahindra Bank at a valuation of over $420m.